Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Trial of Romidepsin and Bortezomib for Multiple Myeloma [Phase 2]
Phase 2 trial of romidepsin plus bortezomib in multiple myeloma was terminated; results posted in 2012.
-
CLINICAL_TRIALS research · 2012-12-17Clinical Trial Update: Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation [Phase 1]
A Phase 1 trial evaluating Cytokine Induced Killer cells as post-transplant immunotherapy after allogeneic hematopoietic cell transplantatio…
-
CLINICAL_TRIALS research · 2012-12-04Clinical Trial Update: Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 safety study evaluating an anti-LewisY chimeric antigen receptor therapy in patients with multiple myeloma, acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma [Phase 1, Phase 2]
The study evaluated the safety and efficacy of P276-00 in relapsed and/or refractory multiple myeloma across Phase 1 and Phase 2 and has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis [Phase 2]
A Phase 2 clinical trial evaluating 4'-Iodo-4'-Deoxydoxorubicin in patients with AL amyloidosis and related plasma cell neoplasms has comple…
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
The trial update describes collecting and storing tissue and DNA samples from patients undergoing donor stem cell transplantation, across mu…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
A Phase 2 clinical trial evaluating donor bone marrow transplantation for various hematologic diseases has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma [Phase 2]
Phase II trial evaluating a Farnesyltransferase inhibitor (FTI) for advanced multiple myeloma has completed. The document notes completion o…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Phase 2]
Phase 2 trial evaluating epoetin alfa for treating chemotherapy-induced anemia in cancer patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer [NA]
A clinical trial update reports completion of a donor stem cell transplant study in older or frail patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Prospective Observational Study on Plerixafor After Chemotherapy
A completed prospective observational study evaluating the use of Plerixafor after chemotherapy in patients with lymphoma or multiple myelom…
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A phase 2 trial evaluating bortezomib for newly diagnosed multiple myeloma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: CI-994 in Treating Patients With Advanced Myeloma [Phase 2]
Phase 2 trial update on CI-994 for advanced multiple myeloma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count [Phase 3]
Phase 3 trial update on preventing infection in patients with hematologic cancers and leukopenia-related fever; the study has been completed…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer [NA]
A clinical trial comparing moxifloxacin with ciprofloxacin plus amoxicillin for fever and neutropenia in cancer patients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update on combining bendamustine with bortezomib for relapsed/refractory multiple myeloma, with Phase 1 and Phase 2 results…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
This completed clinical trial evaluated how well patients adhered to clodronate (Bonefos) therapy across several indications including breas…
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients [Phase 2]
The Phase 2 trial NCT01269203 investigating an NF-kB inhibitor to reduce symptoms during maintenance therapy in multiple myeloma has been wi…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain [Phase 3]
Phase 3 clinical trial evaluating an opioid titration order sheet versus standard care for cancer-related pain; the study is completed with …
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of CAL-101 in relapsed or refractory hematologic malignancies has completed, evaluating safety and preliminary…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma [Phase 2]
Phase 2 trial updates the efficacy and safety of oral CEP-701 (lestaurtinib) in patients with advanced multiple myeloma, with the study term…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies. [Phase 1]
A Phase 1/2, open-label dose-escalation study of elotuzumab in combination with bortezomib for multiple myeloma was terminated.